141 related articles for article (PubMed ID: 19292815)
21. [Breast neoplasms: micrometastasis].
Kosaka Y; Mimori K; Mori M; Moriyama N; Watanabe M
Nihon Rinsho; 2007 Jun; 65 Suppl 6():47-53. PubMed ID: 17682138
[No Abstract] [Full Text] [Related]
22. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of tumor cells in the bone marrow.
Mendoza CB; Moore GE; Crosswhite LH; Sandberg AA; Watne AL
Surg Gynecol Obstet; 1969 Sep; 129(3):483-8. PubMed ID: 5820928
[No Abstract] [Full Text] [Related]
24. Triple negative breast cancer: clinicopathological characteristics and treatment strategies.
Akiyama F; Iwase H
Breast Cancer; 2009; 16(4):252-3. PubMed ID: 19506994
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotype of isolated tumour cells in the blood, bone marrow and lymph nodes of patients with gastric cancer.
Pituch-Noworolska A; Drabik G; Szatanek R; Białas M; Kołodziejczyk P; Szczepanik A; Stachura J; Zembala M
Pol J Pathol; 2007; 58(2):93-7. PubMed ID: 17715675
[TBL] [Abstract][Full Text] [Related]
26. Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features.
Ménard S; Squicciarini P; Luini A; Sacchini V; Rovini D; Tagliabue E; Veronesi P; Salvadori B; Veronesi U; Colnaghi MI
Br J Cancer; 1994 Jun; 69(6):1126-9. PubMed ID: 7911032
[TBL] [Abstract][Full Text] [Related]
27. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
[TBL] [Abstract][Full Text] [Related]
28. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
[TBL] [Abstract][Full Text] [Related]
29. Correlation does not always show a causal relationship.
Buyukhatipoglu H; Homaei-Shandiz F
Saudi Med J; 2007 Jun; 28(6):986; author reply 986. PubMed ID: 17530133
[No Abstract] [Full Text] [Related]
30. [Clinicopathological characteristics and prognosis of patients with breast cancer over 65 years of age].
Gao JD; Zhang BN; Wang X; Wang J; Bi XF
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):83-6. PubMed ID: 19489267
[TBL] [Abstract][Full Text] [Related]
31. [Histological tumor type and bone marrow metastases of cancers of the breast].
Soudah B; Stauch G; Spindler B; Nicolai U; Georgii A
Verh Dtsch Ges Pathol; 1985; 69():338-41. PubMed ID: 4096114
[No Abstract] [Full Text] [Related]
32. Molecular markers of breast axillary lymph node metastasis.
Cavalli LR
Expert Rev Mol Diagn; 2009 Jul; 9(5):441-54. PubMed ID: 19580429
[TBL] [Abstract][Full Text] [Related]
33. Isolated tumor cells in the bone marrow: value of a new diagnostic method in the TNM-staging of solid tumors.
Werner M; Nasarek A; Georgii A
Gen Diagn Pathol; 1996 Jun; 142(1):1-6. PubMed ID: 8793480
[No Abstract] [Full Text] [Related]
34. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
[TBL] [Abstract][Full Text] [Related]
35. The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer.
Matkowski R; Gisterek I; Halon A; Lacko A; Szewczyk K; Staszek U; Pudelko M; Szynglarewicz B; Szelachowska J; Zolnierek A; Kornafel J
Anticancer Res; 2009 Jul; 29(7):2445-51. PubMed ID: 19596912
[TBL] [Abstract][Full Text] [Related]
36. Identification of mammary metastatic cells in the bone marrow as a marker of a minimal residual disease and of their proliferative index as a factor of prognosis--an immunocytologic study with monoclonal antibodies.
Ginsbourg M; Musset M; Misset JL; Genty O; Mathé G
Suppl J Med Oncol Tumor Pharmacother; 1988; 1():51-4. PubMed ID: 3074227
[No Abstract] [Full Text] [Related]
37. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
Bensouda Y; André F; Boulet T; Al-Ghuzlan A; Conforti R; Troalen F; Bourgier C; Errihani H; Spielmann M; Delaloge S
Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005
[TBL] [Abstract][Full Text] [Related]
38. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
[TBL] [Abstract][Full Text] [Related]
39. Proceedings: Primary breast cancer: identification of poor prognosis.
Blamey RW; Elston CR; Davies CJ; Preston B
Br J Surg; 1976 Feb; 63(2):158. PubMed ID: 1252753
[No Abstract] [Full Text] [Related]
40. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.
Pitini V; Arrigo C; Righi M
Cancer; 2005 Sep; 104(6):1332-3; author reply 1333. PubMed ID: 16078268
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
